Clinical Evaluator Outcomes Reliability Study
This trial is active, not recruiting.
|Sponsor||Cooperative International Neuromuscular Research Group|
|Start date||May 2014|
|End date||December 2016|
|Trial size||55 participants|
|Trial identifier||NCT02146586, CNMC0713|
This study outlines structured Clinical Evaluator (CE) testing techniques that are proposed to be implemented across all sites participating in the Cooperative International Neuromuscular Research Group (CINRG) research studies. The study will determine if the selected techniques are reliable and reproducible across the CINRG network by evaluating the reliability and reproducibility of the measures between CEs
Clinical Evaluator Assessments
time frame: One time visit
Male participants at least 6 years old.
Dystrophinopathy Participant Inclusion Criteria: - Site confirmed genetic diagnosis of a dystrophinopathy - Aged 6 years and older - Able to transfer to testing table - Able to walk 10 meters without an assistive device Dystrophinopathy Participant Exclusion Criteria: - Investigator assessment of inability to comply with protocol assessments - Participants who have attention deficient disorder or other cognitive conditions that may limit attention span to perform protocol assessments
|Official title||Cooperative International Neuromuscular Research Group (CINRG) Clinical Evaluator Outcomes Reliability Study|
|Principal investigator||Lauren Morgenroth, MS, CGC|
Call for more information